Gene fusion discovery may lead to improved prostate cancer test
A newly discovered gene fusion is highly expressed in a subset of prostate cancers, according to a study by researchers at Weill Cornell Medical College. The findings, reported in the April 1 issue of Cancer Research, may lead to more accurate tests for prostate cancer. The gene fusion biomarker is also a different type of fusion than researchers have found in cancer previously and may represent an entirely new mechanism that cancer cells use to outgrow their healthy neighbors. The SLC45A3-ELK4 gene fusion is detectable at high levels in the urine of some men at risk for prostate cancer. If these data are validated, it may be that in the future men could be tested for prostate cancer through a simple urine test. If the fusion gene is present at a high level, they likely have the disease, and if not, they likely don't have it.
"We think this is going to be a potentially important diagnostic marker in prostate cancer," says senior author Dr. Mark A. Rubin, the Homer T. Hirst Professor of Oncology in Pathology, professor of pathology and laboratory medicine, and vice chair for experimental pathology at Weill Cornell Medical College. "PSA testing is inadequate. PSA detects men with cancer but also many men with benign conditions. As we have seen recently from two major studies on PSA screening, for every 50 men with a positive PSA screening, only one man's life is saved. We urgently need biomarkers to detect clinically significant prostate cancer."
"Our work has a long-term goal of achieving a test that distinguishes clinically significant prostate cancer from indolent disease that does not require additional treatment. With better diagnosis, we will be able to treat cancer patients with individualized therapies -- one of the main goals of the Cancer Center at NewYork-Presbyterian Hospital/Weill Cornell Medical Center," continues Dr. Rubin, who is the Center's associate director of translational research and a pathologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
Dr. Rubin's team is already working with a company to develop a urine test for prostate cancer using a chromosome-based gene fusion called TMPRSS2-ERG that the team discovered previously while working with members of Dr. Arul Chinnaiyan's research group at the University of Michigan. Dr. Rubin anticipates that the newly discovered SLC45A3-ELK4 gene fusion may be added to that urine test in the future to increase its accuracy and also to potentially help determine the level of response to certain non-surgical systemic treatments. The TMPRSS2-ERG urine test is being evaluated in multiple early clinical trials in the United States and Europe.
Novel Gene Fusion Sheds Light on How Cancer Works
Unlike the gene fusions previously found in cancers, which arise when two chromosomes join together in an abnormal way, the new fusion occurs when the genes are being copied into RNA. The two genes, SLC45A3 and ELK4, reside next to one another on the chromosome in normal and prostate cancer cells. However, when the genes are copied into RNA in the prostate cancer cells, they frequently generate a single RNA message that fuses information from both genes. Ongoing work is exploring the potential biologic implications of this discovery. However, the diagnostic implications are more immediate because these types of genetic chimera occur at significantly higher levels in abnormal tumor cells.
"We think this type of gene fusion might be a common mechanism in cancer," Dr. Rubin says. "This expands our understanding of how tumor cells may hijack androgen-regulated genes with neighboring genes and effectively alter its regulation. This may be a way tumors gain a competitive advantage."
Source: New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Articles on the same topic
- Statins alter prostate cancer patients' PSA levelsTue, 28 Apr 2009, 19:50:15 UTC
- Vitamin E, selenium and soy in combination does not prevent prostate cancerSun, 26 Apr 2009, 13:25:21 UTC
- Men treated for localized prostate cancer could benefit from pomegranate juice consumptionSun, 26 Apr 2009, 13:25:18 UTC
- Major statin study reveals several important findings for reducing prostate cancer and diseaseSun, 26 Apr 2009, 5:38:57 UTC
- Statins may exert influence on prostate cancer growth by reducing inflammationSun, 26 Apr 2009, 4:30:29 UTC
- MRI: Effective tool for determining pathologic stage of prostate cancerThu, 23 Apr 2009, 15:58:24 UTC
- Autopsy study links prostate cancer to single rogue cellFri, 17 Apr 2009, 21:08:52 UTC
- New drug shows promise in treating drug-resistant prostate cancerFri, 10 Apr 2009, 14:24:39 UTC
- Drug shows activity in men with advanced prostate cancerWed, 8 Apr 2009, 18:51:56 UTC
- New medications show promise in treating drug-resistant prostate cancerTue, 7 Apr 2009, 19:50:19 UTC
- A potential new target for treatment of hormone refractory prostate cancerMon, 6 Apr 2009, 16:22:28 UTC
Other sources
- Statins Alter Prostate Cancer Patients' PSA Levelsfrom Science DailyWed, 29 Apr 2009, 16:21:05 UTC
- Study bolsters hopes for prostate cancer vaccine rejected by FDAfrom LA Times - ScienceWed, 29 Apr 2009, 7:14:16 UTC
- Statins alter prostate cancer patients' PSA levelsfrom PhysorgTue, 28 Apr 2009, 19:49:04 UTC
- Prostate cancer vaccine extends survival in studyfrom PhysorgTue, 28 Apr 2009, 18:42:10 UTC
- 3-D used to study prostate cancer spreadfrom UPITue, 28 Apr 2009, 16:21:04 UTC
- Avodart, Prostate Drug, Found to Reduce Cancer Riskfrom NY Times HealthTue, 28 Apr 2009, 4:00:11 UTC
- Doctors urge baseline test for prostate cancerfrom PhysorgMon, 27 Apr 2009, 10:21:23 UTC
- Doctors urge baseline test for prostate cancerfrom AP HealthMon, 27 Apr 2009, 4:21:03 UTC
- Statins May Exert Influence On Prostate Cancer Growth By Reducing Inflammationfrom Science DailySun, 26 Apr 2009, 20:57:36 UTC
- Major Statin Study Reveals Several Important Findings For Reducing Prostate Cancer And Diseasefrom Science DailySun, 26 Apr 2009, 20:57:35 UTC
- Suppressor Of Cytokine Signaling (SOCS)-1 Inhibits Prostate Cancer Growthfrom Science DailySun, 26 Apr 2009, 20:57:29 UTC
- Vitamin E, selenium and soy in combination does not prevent prostate cancerfrom PhysorgSun, 26 Apr 2009, 16:56:10 UTC
- Vitamin E, Selenium And Soy In Combination Does Not Prevent Prostate Cancerfrom Science DailySun, 26 Apr 2009, 13:21:57 UTC
- Men Treated For Localized Prostate Cancer Could Benefit From Pomegranate Juice Consumptionfrom Science DailySun, 26 Apr 2009, 13:21:55 UTC
- Statins May Exert Influence On Prostate Cancer Growth By Reducing Inflammationfrom Science DailySun, 26 Apr 2009, 13:21:41 UTC
- Major Statin Study Reveals Several Important Findings For Reducing Prostate Cancer And Diseasefrom Science DailySun, 26 Apr 2009, 13:21:38 UTC
- Suppressor Of Cytokine Signaling (SOCS)-1 Inhibits Prostate Cancer Growthfrom Science DailySun, 26 Apr 2009, 13:21:30 UTC
- Statins may exert influence on prostate cancer growth by reducing inflammationfrom Science BlogSun, 26 Apr 2009, 5:35:24 UTC
- MRI: Effective tool for determining pathologic stage of prostate cancerfrom Science BlogThu, 23 Apr 2009, 16:35:21 UTC
- Potential genetic prostate cancer variation foundfrom PhysorgTue, 21 Apr 2009, 12:28:06 UTC
- Designer immune cells fight prostate cancerfrom News @ NatureMon, 20 Apr 2009, 20:14:31 UTC
- Autopsy study links prostate cancer to single rogue cellfrom Biology News NetSat, 18 Apr 2009, 17:07:17 UTC
- Autopsy Study Links Prostate Cancer To Single Rogue Cellfrom Science DailySat, 18 Apr 2009, 1:35:50 UTC
- Autopsy study links prostate cancer to single rogue cellfrom Science BlogFri, 17 Apr 2009, 21:49:22 UTC
- Autopsy study links prostate cancer to single rogue cellfrom PhysorgFri, 17 Apr 2009, 21:28:10 UTC
- Gene Fusion Discovery May Lead To Improved Prostate Cancer Testfrom Science DailyThu, 16 Apr 2009, 1:35:10 UTC
- Company says prostate cancer vaccine shows promisefrom PhysorgTue, 14 Apr 2009, 15:42:31 UTC
- Company says prostate cancer vaccine shows promisefrom AP HealthTue, 14 Apr 2009, 15:21:26 UTC
- Promising Test for Dendreon’s Prostate Cancer Drugfrom NY Times HealthTue, 14 Apr 2009, 14:56:10 UTC
- Potential New Target For Treatment Of Hormone Refractory Prostate Cancerfrom Science DailyTue, 14 Apr 2009, 2:28:30 UTC
- Drug Shows Activity In Men With Advanced Prostate Cancerfrom Science DailyMon, 13 Apr 2009, 13:21:32 UTC
- New Drug Shows Promise In Treating Drug-resistant Prostate Cancerfrom Science DailySat, 11 Apr 2009, 4:07:20 UTC
- New drug shows promise in treating drug-resistant prostate cancerfrom Science BlogFri, 10 Apr 2009, 14:35:06 UTC
- Gene fusion discovery may lead to improved prostate cancer testfrom Science BlogThu, 9 Apr 2009, 21:42:19 UTC
- Gene fusion discovery may lead to improved prostate cancer testfrom PhysorgThu, 9 Apr 2009, 21:21:13 UTC
- New prostate cancer drugs show promisefrom UPIWed, 8 Apr 2009, 19:14:12 UTC
- A New Tool for Battling Prostate Cancerfrom Science NOWTue, 7 Apr 2009, 22:28:04 UTC
- Prostate drug shows promise in early testingfrom PhysorgTue, 7 Apr 2009, 21:56:20 UTC
- Experimental prostate cancer drug shows promisefrom CBC: HealthTue, 7 Apr 2009, 21:21:15 UTC
- New medications show promise in treating drug-resistant prostate cancerfrom Science BlogTue, 7 Apr 2009, 20:49:23 UTC
- Prostate drug shows promise in early testingfrom AP HealthTue, 7 Apr 2009, 19:28:05 UTC
- Drug trial gives hope of longer life to women fighting ovarian cancerfrom The Guardian - ScienceTue, 7 Apr 2009, 7:42:37 UTC
- A potential new target for treatment of hormone refractory prostate cancerfrom PhysorgMon, 6 Apr 2009, 18:42:09 UTC
- A potential new target for treatment of hormone refractory prostate cancerfrom Science BlogMon, 6 Apr 2009, 16:49:04 UTC
- New Marker For Prostate Cancer Progressionfrom Science DailyThu, 2 Apr 2009, 16:21:24 UTC